SEIDENBERG BETH C - Insider Non-Derivative Transactions at Atara Biotherapeutics, Inc. (ATRA) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on May 31, 2023, SEIDENBERG BETH C's relationship to Atara Biotherapeutics, Inc. (ATRA) is Director, and currently has 115,689 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ATRA insiders.
Data Source: SEC.
SEIDENBERG BETH C - Insider Non-Derivative Transactions at ATRA
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 1, 2023 | Acquisition -- (Common Stock) | 57000 | 0 | 115689 |